- Home
- GENC vs TSVT Comparison
GENC vs TSVT Comparison
Compare GENC & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GENC
- TSVT
- Stock Information
- Founded
- GENC 1894
- TSVT 2021
- Country
- GENC United States
- TSVT United States
- Employees
- GENC N/A
- TSVT N/A
- Industry
- GENC Construction/Ag Equipment/Trucks
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- GENC Industrials
- TSVT Health Care
- Exchange
- GENC Nasdaq
- TSVT Nasdaq
- Market Cap
- GENC 263.5M
- TSVT 151.7M
- IPO Year
- GENC N/A
- TSVT N/A
- Fundamental
- Price
- GENC $17.10
- TSVT $2.96
- Analyst Decision
- GENC
- TSVT Buy
- Analyst Count
- GENC 0
- TSVT 6
- Target Price
- GENC N/A
- TSVT $10.40
- AVG Volume (30 Days)
- GENC 29.2K
- TSVT 380.9K
- Earning Date
- GENC 02-04-2025
- TSVT 11-12-2024
- Dividend Yield
- GENC N/A
- TSVT N/A
- EPS Growth
- GENC 35.02
- TSVT N/A
- EPS
- GENC 1.11
- TSVT N/A
- Revenue
- GENC $113,116,000.00
- TSVT $45,620,000.00
- Revenue This Year
- GENC N/A
- TSVT N/A
- Revenue Next Year
- GENC N/A
- TSVT $36.09
- P/E Ratio
- GENC $15.97
- TSVT N/A
- Revenue Growth
- GENC 5.44
- TSVT N/A
- 52 Week Low
- GENC $15.24
- TSVT $2.78
- 52 Week High
- GENC $24.88
- TSVT $6.40
- Technical
- Relative Strength Index (RSI)
- GENC 27.79
- TSVT 37.22
- Support Level
- GENC $16.50
- TSVT $2.83
- Resistance Level
- GENC $18.18
- TSVT $3.22
- Average True Range (ATR)
- GENC 1.07
- TSVT 0.23
- MACD
- GENC -0.31
- TSVT 0.00
- Stochastic Oscillator
- GENC 11.74
- TSVT 19.25
About GENC Gencor Industries Inc.
Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.